@article{100764,
  keywords = {aminopyridine, Chagas disease, Drug Design, human african trypanosiomasis, leischmaniasis, Neglected Tropical Diseases, pharmacochemical properties, pharmacokinetic properties},
  author = {Mustière R and Dassonville-Klimpt A and Sonnet P},
  title = {Aminopyridines in the development of drug candidates against protozoan neglected tropical diseases.},
  abstract = {<p>Neglected tropical diseases (NTDs) pose a major threat in tropical zones for impoverished populations. Difficulty of access, adverse effects or low efficacy limit the use of current therapeutic options. Therefore, development of new drugs against NTDs is a necessity. Compounds containing an aminopyridine (AP) moiety are of great interest for the design of new anti-NTD drugs due to their intrinsic properties compared with their closest chemical structures. Currently, over 40 compounds with an AP moiety are on the market, but none is used against NTDs despite active research on APs. The aim of this review is to present the medicinal chemistry work carried out with these scaffolds, against protozoan NTDs:&nbsp;Trypanosoma cruzi,&nbsp;Trypanosoma brucei&nbsp;or&nbsp;Leishmania spp.</p>
},
  year = {2024},
  journal = {Future medicinal chemistry},
  volume = {16},
  pages = {1357-1373},
  month = {07/2024},
  issn = {1756-8927},
  doi = {10.1080/17568919.2024.2359361},
  language = {ENG},
}